Skip to main content

Table 1 Laboratory data on admission

From: A case of minimal change disease after the administration of anti receptor activator of nuclear factor kappa B ligand (RANKL) monoclonal antibody: a case report

Urinalysis
 Protein 11.7 g/g Cr
  Selectivity Index 0.05  
 Occult blood (3+)  
 RBC 10-19 /HPF
 WBC 1-4 /HPF
 Squamous cell <1 /HPF
 Transitional cell (-)  
 Tubular epithelial cell 5-9 /HPF
 Hyaline cast 1+  
 Epithelial cast 1+  
 Granular cast (-)  
 Waxy cast (-)  
 Fatty cast (-)  
 RBC cast (-)  
 WBC cast (-)  
Blood count
 WBC 7.60×103 /μL
 RBC 4.27×106 /μL
 Hb 12.7 g/dL
 Ht 37.8 %
 Plt 19.5×104 /μL
Biochemical test
 TP 4.0 g/dL
 Alb 1.5 g/dL
 AST 22 IU/L
 ALT 13 IU/L
 LD 290 IU/L
 γ-GTP 26 IU/L
 ALP 245 IU/L
 T-Bil 0.3 mg/dL
 CK 164 IU/L
 UN 15 mg/dL
 Cr 0.61 mg/dL
 UA 7.1 mg/dL
 Na 143 mEq/L
 K 3.5 mEq/L
 Cl 113 mEq/L
 Ca 6.7 mg/dL
 IP 2.5 mg/dL
 BS 131 mg/dL
 HbA1c 5.3 %
 T-Cho 376 mg/dL
 TG 277 mg/dL
 HDL-Cho 50 mg/dL
Immunological test
 CRP 1.0 mg/dL
 IgG 453 mg/dL
 IgA 299 mg/dL
 IgM 67 mg/dL
 IgE 147 IU/mL
 C3 137 mg/dL
 C4 41 mg/dL
 CH50 60  
 ANA (-)  
 MPO-ANCA <1.0 U/mL
 PR3-ANCA <1.0 U/mL
 GBM <2.0 U/mL
Infection
 HBs-Ag (-)  
 HBs-Ab (-)  
 HBc-Ab (-)  
 HCV-Ab (-)